

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of cAMP-mediated signaling (GO:0043950) | 6.71354988 |
| 2 | positive regulation of type 2 immune response (GO:0002830) | 6.28427449 |
| 3 | T cell migration (GO:0072678) | 5.86497026 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.59607323 |
| 5 | cellular response to ethanol (GO:0071361) | 5.54005892 |
| 6 | virion attachment to host cell (GO:0019062) | 5.44301399 |
| 7 | adhesion of symbiont to host cell (GO:0044650) | 5.44301399 |
| 8 | type I interferon signaling pathway (GO:0060337) | 5.31409777 |
| 9 | cellular response to type I interferon (GO:0071357) | 5.31409777 |
| 10 | response to type I interferon (GO:0034340) | 5.22892467 |
| 11 | positive regulation of monocyte chemotaxis (GO:0090026) | 5.10063048 |
| 12 | negative regulation of interleukin-12 production (GO:0032695) | 4.98468510 |
| 13 | monocyte chemotaxis (GO:0002548) | 4.85113942 |
| 14 | protein heterotrimerization (GO:0070208) | 4.71882989 |
| 15 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.66926154 |
| 16 | adhesion of symbiont to host (GO:0044406) | 4.61074455 |
| 17 | regulation of monocyte chemotaxis (GO:0090025) | 4.45134683 |
| 18 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.44281261 |
| 19 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.30110156 |
| 20 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.28521301 |
| 21 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.24424922 |
| 22 | regulation of type 2 immune response (GO:0002828) | 4.17305546 |
| 23 | regulation of tolerance induction (GO:0002643) | 4.12297899 |
| 24 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 4.08490229 |
| 25 | regulation of hypersensitivity (GO:0002883) | 4.07609897 |
| 26 | T-helper 1 type immune response (GO:0042088) | 4.05530763 |
| 27 | B cell mediated immunity (GO:0019724) | 4.03113623 |
| 28 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 4.02225341 |
| 29 | negative regulation of viral genome replication (GO:0045071) | 4.00699031 |
| 30 | negative regulation of granulocyte differentiation (GO:0030853) | 3.96842315 |
| 31 | response to peptidoglycan (GO:0032494) | 3.95328053 |
| 32 | cellular response to interferon-gamma (GO:0071346) | 3.94097994 |
| 33 | keratan sulfate catabolic process (GO:0042340) | 3.93647606 |
| 34 | cytidine deamination (GO:0009972) | 3.91013627 |
| 35 | cytidine metabolic process (GO:0046087) | 3.91013627 |
| 36 | cytidine catabolic process (GO:0006216) | 3.91013627 |
| 37 | positive regulation of macrophage cytokine production (GO:0060907) | 3.90817325 |
| 38 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.87236013 |
| 39 | positive regulation of lymphocyte migration (GO:2000403) | 3.86610315 |
| 40 | cellular response to exogenous dsRNA (GO:0071360) | 3.86222303 |
| 41 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.85453108 |
| 42 | sexual reproduction (GO:0019953) | 3.84491080 |
| 43 | response to interferon-gamma (GO:0034341) | 3.82382102 |
| 44 | apoptotic cell clearance (GO:0043277) | 3.79691925 |
| 45 | regulation of lymphocyte migration (GO:2000401) | 3.75211359 |
| 46 | regulation of cAMP-mediated signaling (GO:0043949) | 3.75076018 |
| 47 | response to interferon-beta (GO:0035456) | 3.68274966 |
| 48 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.66488312 |
| 49 | phagocytosis, engulfment (GO:0006911) | 3.64802567 |
| 50 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.62598426 |
| 51 | regulation of chronic inflammatory response (GO:0002676) | 3.62108911 |
| 52 | microglial cell activation (GO:0001774) | 3.60711217 |
| 53 | cellular extravasation (GO:0045123) | 3.60233869 |
| 54 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.59916204 |
| 55 | regulation of macrophage chemotaxis (GO:0010758) | 3.59203508 |
| 56 | macrophage activation involved in immune response (GO:0002281) | 3.58643664 |
| 57 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.56039613 |
| 58 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.56039613 |
| 59 | modulation by symbiont of host immune response (GO:0052553) | 3.56039613 |
| 60 | positive regulation by symbiont of host defense response (GO:0052509) | 3.56039613 |
| 61 | modulation by symbiont of host defense response (GO:0052031) | 3.56039613 |
| 62 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.56039613 |
| 63 | sequestering of actin monomers (GO:0042989) | 3.55165300 |
| 64 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.54781671 |
| 65 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.50760391 |
| 66 | cellular response to interferon-beta (GO:0035458) | 3.48818761 |
| 67 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.46547923 |
| 68 | neutrophil activation involved in immune response (GO:0002283) | 3.45831835 |
| 69 | pinocytosis (GO:0006907) | 3.44249374 |
| 70 | regulation of cholesterol storage (GO:0010885) | 3.42967514 |
| 71 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.41798529 |
| 72 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.37927793 |
| 73 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.37513416 |
| 74 | myeloid dendritic cell differentiation (GO:0043011) | 3.35318943 |
| 75 | defense response to virus (GO:0051607) | 3.32991942 |
| 76 | immunoglobulin mediated immune response (GO:0016064) | 3.31381841 |
| 77 | positive regulation of cholesterol efflux (GO:0010875) | 3.31297199 |
| 78 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.29745032 |
| 79 | collagen fibril organization (GO:0030199) | 3.28926768 |
| 80 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.28365745 |
| 81 | cellular response to lipopolysaccharide (GO:0071222) | 3.27972933 |
| 82 | defense response to protozoan (GO:0042832) | 3.26594808 |
| 83 | lymphocyte migration (GO:0072676) | 3.24874486 |
| 84 | chemokine-mediated signaling pathway (GO:0070098) | 3.22546629 |
| 85 | cellular response to molecule of bacterial origin (GO:0071219) | 3.21228007 |
| 86 | hair cycle (GO:0042633) | 3.20832491 |
| 87 | molting cycle (GO:0042303) | 3.20832491 |
| 88 | regulation of T-helper cell differentiation (GO:0045622) | 3.19932432 |
| 89 | regulation of interleukin-12 production (GO:0032655) | 3.19324811 |
| 90 | regulation of granulocyte chemotaxis (GO:0071622) | 3.17392817 |
| 91 | regulation of mononuclear cell migration (GO:0071675) | 3.16196768 |
| 92 | granulocyte chemotaxis (GO:0071621) | 3.15064147 |
| 93 | regulation of T cell tolerance induction (GO:0002664) | 3.14799037 |
| 94 | regulation of macrophage cytokine production (GO:0010935) | 3.14407664 |
| 95 | positive regulation of interleukin-10 production (GO:0032733) | 3.14073671 |
| 96 | kynurenine metabolic process (GO:0070189) | 3.12755135 |
| 97 | regulation of interleukin-10 production (GO:0032653) | 3.11958721 |
| 98 | positive regulation of antigen processing and presentation (GO:0002579) | 3.11810491 |
| 99 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.10425050 |
| 100 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.07827421 |
| 101 | collagen metabolic process (GO:0032963) | 3.07769571 |
| 102 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.07709675 |
| 103 | response to protozoan (GO:0001562) | 3.07563003 |
| 104 | collagen catabolic process (GO:0030574) | 3.06859204 |
| 105 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.06838485 |
| 106 | complement activation, alternative pathway (GO:0006957) | 3.06815287 |
| 107 | cellular response to interferon-alpha (GO:0035457) | 3.05636432 |
| 108 | positive regulation of sterol transport (GO:0032373) | 3.05080412 |
| 109 | positive regulation of cholesterol transport (GO:0032376) | 3.05080412 |
| 110 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.04082243 |
| 111 | low-density lipoprotein particle clearance (GO:0034383) | 3.03264127 |
| 112 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.03170070 |
| 113 | complement activation (GO:0006956) | 3.03013425 |
| 114 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.01803318 |
| 115 | granulocyte migration (GO:0097530) | 3.01258082 |
| 116 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.00085628 |
| 117 | positive regulation of leukocyte migration (GO:0002687) | 2.99136565 |
| 118 | positive regulation of release of sequestered calcium ion into cytosol (GO:0051281) | 2.98377398 |
| 119 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.98343900 |
| 120 | skin morphogenesis (GO:0043589) | 2.98335187 |
| 121 | phagocytosis, recognition (GO:0006910) | 2.97752095 |
| 122 | macrophage activation (GO:0042116) | 2.96841097 |
| 123 | detection of molecule of bacterial origin (GO:0032490) | 2.96274258 |
| 124 | positive regulation of interleukin-12 production (GO:0032735) | 2.94813667 |
| 125 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.94198199 |
| 126 | dendritic cell differentiation (GO:0097028) | 2.93410127 |
| 127 | positive regulation of acute inflammatory response (GO:0002675) | 2.92644905 |
| 128 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.92570001 |
| 129 | interferon-gamma secretion (GO:0072643) | 2.92367924 |
| 130 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.92329458 |
| 131 | eosinophil chemotaxis (GO:0048245) | 2.89861268 |
| 132 | mannose metabolic process (GO:0006013) | 2.87310787 |
| 133 | multicellular organismal catabolic process (GO:0044243) | 2.84669198 |
| 134 | response to lipoprotein particle (GO:0055094) | 2.82911723 |
| 135 | complement activation, classical pathway (GO:0006958) | 2.81392108 |
| 136 | negative regulation of heart growth (GO:0061117) | 2.81253705 |
| 137 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.81253705 |
| 138 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.79832876 |
| 139 | cortical actin cytoskeleton organization (GO:0030866) | 2.79817326 |
| 140 | positive regulation of interferon-alpha production (GO:0032727) | 2.78173535 |
| 141 | multicellular organismal metabolic process (GO:0044236) | 2.78010485 |
| 142 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.76372867 |
| 143 | fibril organization (GO:0097435) | 2.75148089 |
| 144 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.73751662 |
| 145 | extracellular fibril organization (GO:0043206) | 2.73670068 |
| 146 | regulation of complement activation (GO:0030449) | 2.72753730 |
| 147 | response to interferon-alpha (GO:0035455) | 2.71286846 |
| 148 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.71258769 |
| 149 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.70922256 |
| 150 | response to acidic pH (GO:0010447) | 2.70528427 |
| 151 | positive regulation of leukocyte chemotaxis (GO:0002690) | 2.70000143 |
| 152 | peptide cross-linking (GO:0018149) | 2.67464805 |
| 153 | phospholipid efflux (GO:0033700) | 2.65865980 |
| 154 | lipoprotein transport (GO:0042953) | 2.63155772 |
| 155 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.63081531 |
| 156 | regulation of interferon-alpha production (GO:0032647) | 2.61569382 |
| 157 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.60826133 |
| 158 | endothelial cell chemotaxis (GO:0035767) | 2.60082740 |
| 159 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.59837079 |
| 160 | cortical cytoskeleton organization (GO:0030865) | 2.59653540 |
| 161 | regulation of antigen processing and presentation (GO:0002577) | 2.59472079 |
| 162 | lymphocyte chemotaxis (GO:0048247) | 2.56923931 |
| 163 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.56310691 |
| 164 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.54388447 |
| 165 | regulation of leukocyte chemotaxis (GO:0002688) | 2.53959614 |
| 166 | membrane invagination (GO:0010324) | 2.53895847 |
| 167 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.52682641 |
| 168 | basement membrane organization (GO:0071711) | 2.51513014 |
| 169 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.49652327 |
| 170 | stress fiber assembly (GO:0043149) | 2.48421879 |
| 171 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.47343348 |
| 172 | eosinophil migration (GO:0072677) | 2.46466464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.62740355 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.49570367 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.04338391 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 3.99253650 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.72996136 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.62276548 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.29663174 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.20767886 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.18362155 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15373471 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.02628547 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.78255955 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.63096217 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.59522344 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.34294543 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.25680497 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.20669974 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.17216833 |
| 19 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.11944873 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.87351567 |
| 21 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.79952401 |
| 22 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.77902206 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.76898708 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.76478644 |
| 25 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.71627673 |
| 26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66668646 |
| 27 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.65050088 |
| 28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.64517645 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.63528121 |
| 30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.60904033 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.56816175 |
| 32 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.56468918 |
| 33 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52396440 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.51304801 |
| 35 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.51104475 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.50131316 |
| 37 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.49525122 |
| 38 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.49352892 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.48526311 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48316769 |
| 41 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.47888251 |
| 42 | CJUN_26792858_Chip-Seq_BT549_Human | 1.47189604 |
| 43 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.46854727 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.44987634 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41871184 |
| 46 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.41410327 |
| 47 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.38486472 |
| 48 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.37824429 |
| 49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35913135 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.33445913 |
| 51 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32854557 |
| 52 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.30327207 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.29452550 |
| 54 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27848145 |
| 55 | MYB_26560356_Chip-Seq_TH2_Human | 1.27483585 |
| 56 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26552348 |
| 57 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.25125906 |
| 58 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.25024636 |
| 59 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.24605262 |
| 60 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23346100 |
| 61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22489940 |
| 62 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20057821 |
| 63 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.19876423 |
| 64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19789745 |
| 65 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.15844625 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15562044 |
| 67 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14992219 |
| 68 | MAF_26560356_Chip-Seq_TH1_Human | 1.13249389 |
| 69 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.12489631 |
| 70 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.11814630 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11025500 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.10755584 |
| 73 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10632671 |
| 74 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.09806909 |
| 75 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09732358 |
| 76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09707556 |
| 77 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.08440798 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08324163 |
| 79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07903414 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07560710 |
| 81 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.07474537 |
| 82 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.07474537 |
| 83 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.07285025 |
| 84 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06922369 |
| 85 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06413368 |
| 86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06308733 |
| 87 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06083415 |
| 88 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05558877 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04638985 |
| 90 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.04566923 |
| 91 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03998213 |
| 92 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.03570936 |
| 93 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03145414 |
| 94 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01759702 |
| 95 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98943845 |
| 96 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98167970 |
| 97 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.97769975 |
| 98 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97409370 |
| 99 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97189079 |
| 100 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96764151 |
| 101 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94575440 |
| 102 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93102552 |
| 103 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93035334 |
| 104 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92886137 |
| 105 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.92228021 |
| 106 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.92202792 |
| 107 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.91348057 |
| 108 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90952868 |
| 109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90472218 |
| 110 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.90399679 |
| 111 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.89965261 |
| 112 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.89306056 |
| 113 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88966928 |
| 114 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.88903886 |
| 115 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88775951 |
| 116 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.88614996 |
| 117 | MYB_26560356_Chip-Seq_TH1_Human | 0.88572433 |
| 118 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.88538782 |
| 119 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.88134240 |
| 120 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.88115998 |
| 121 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.86893237 |
| 122 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.86765676 |
| 123 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86576929 |
| 124 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86015337 |
| 125 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.76649253 |
| 126 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.74410028 |
| 127 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.73491830 |
| 128 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65081242 |
| 129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64171654 |
| 130 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.62398146 |
| 131 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.62231679 |
| 132 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.58794844 |
| 133 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.56909420 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.54971875 |
| 135 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.54702667 |
| 136 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.53867246 |
| 137 | MAF_26560356_Chip-Seq_TH2_Human | 0.53350942 |
| 138 | UTX_26944678_Chip-Seq_JUKART_Human | 0.53053160 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 7.59236490 |
| 2 | MP0005275_abnormal_skin_tensile | 5.82068927 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.79235254 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 3.72174219 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.41875685 |
| 6 | MP0005503_abnormal_tendon_morphology | 3.30868861 |
| 7 | MP0009840_abnormal_foam_cell | 2.66480899 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.66222062 |
| 9 | MP0003436_decreased_susceptibility_to | 2.47586849 |
| 10 | MP0000343_altered_response_to | 2.41930964 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.28262694 |
| 12 | MP0003279_aneurysm | 2.21239943 |
| 13 | MP0002254_reproductive_system_inflammat | 2.12626682 |
| 14 | MP0005167_abnormal_blood-brain_barrier | 2.11839092 |
| 15 | MP0001533_abnormal_skeleton_physiology | 2.09650660 |
| 16 | MP0002060_abnormal_skin_morphology | 2.08018284 |
| 17 | MP0002419_abnormal_innate_immunity | 2.03674301 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.00701511 |
| 19 | MP0003724_increased_susceptibility_to | 1.99403055 |
| 20 | MP0000604_amyloidosis | 1.90949504 |
| 21 | MP0005000_abnormal_immune_tolerance | 1.70230673 |
| 22 | MP0010368_abnormal_lymphatic_system | 1.69707427 |
| 23 | MP0001958_emphysema | 1.67145313 |
| 24 | MP0003690_abnormal_glial_cell | 1.66548877 |
| 25 | MP0003303_peritoneal_inflammation | 1.63282037 |
| 26 | MP0005025_abnormal_response_to | 1.63048224 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.61572019 |
| 28 | MP0000569_abnormal_digit_pigmentation | 1.60737058 |
| 29 | MP0000920_abnormal_myelination | 1.60647982 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.55591633 |
| 31 | MP0002277_abnormal_respiratory_mucosa | 1.54981370 |
| 32 | MP0003448_altered_tumor_morphology | 1.54339589 |
| 33 | MP0003566_abnormal_cell_adhesion | 1.53576746 |
| 34 | MP0001243_abnormal_dermal_layer | 1.53399063 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.50405583 |
| 36 | MP0002796_impaired_skin_barrier | 1.46403188 |
| 37 | MP0003075_altered_response_to | 1.40687386 |
| 38 | MP0002295_abnormal_pulmonary_circulatio | 1.40599916 |
| 39 | MP0003195_calcinosis | 1.35698482 |
| 40 | MP0004130_abnormal_muscle_cell | 1.35277608 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.34193819 |
| 42 | MP0001790_abnormal_immune_system | 1.33922132 |
| 43 | MP0005387_immune_system_phenotype | 1.33922132 |
| 44 | MP0000685_abnormal_immune_system | 1.33094540 |
| 45 | MP0000716_abnormal_immune_system | 1.32785313 |
| 46 | MP0005390_skeleton_phenotype | 1.32043983 |
| 47 | MP0002933_joint_inflammation | 1.29157401 |
| 48 | MP0006054_spinal_hemorrhage | 1.27614151 |
| 49 | MP0006082_CNS_inflammation | 1.25679024 |
| 50 | MP0002452_abnormal_antigen_presenting | 1.24605568 |
| 51 | MP0005023_abnormal_wound_healing | 1.23710360 |
| 52 | MP0004185_abnormal_adipocyte_glucose | 1.23097598 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.19807294 |
| 54 | MP0005451_abnormal_body_composition | 1.18873923 |
| 55 | MP0004510_myositis | 1.16889137 |
| 56 | MP0001853_heart_inflammation | 1.15318047 |
| 57 | MP0009785_altered_susceptibility_to | 1.14033972 |
| 58 | MP0009278_abnormal_bone_marrow | 1.11441662 |
| 59 | MP0001542_abnormal_bone_strength | 1.09245462 |
| 60 | MP0001800_abnormal_humoral_immune | 1.08354642 |
| 61 | MP0005666_abnormal_adipose_tissue | 1.06681818 |
| 62 | MP0004883_abnormal_blood_vessel | 1.05689528 |
| 63 | MP0005464_abnormal_platelet_physiology | 1.05128338 |
| 64 | MP0005166_decreased_susceptibility_to | 1.04297607 |
| 65 | MP0005164_abnormal_response_to | 1.03799455 |
| 66 | MP0002723_abnormal_immune_serum | 1.03471120 |
| 67 | MP0002405_respiratory_system_inflammati | 1.03345867 |
| 68 | MP0003453_abnormal_keratinocyte_physiol | 1.02294535 |
| 69 | MP0002166_altered_tumor_susceptibility | 1.01407161 |
| 70 | MP0005670_abnormal_white_adipose | 1.01354122 |
| 71 | MP0009764_decreased_sensitivity_to | 1.00312269 |
| 72 | MP0002429_abnormal_blood_cell | 0.98302079 |
| 73 | MP0002398_abnormal_bone_marrow | 0.96810884 |
| 74 | MP0001879_abnormal_lymphatic_vessel | 0.96676075 |
| 75 | MP0001845_abnormal_inflammatory_respons | 0.96271090 |
| 76 | MP0002420_abnormal_adaptive_immunity | 0.95752045 |
| 77 | MP0004947_skin_inflammation | 0.95241405 |
| 78 | MP0001819_abnormal_immune_cell | 0.95179273 |
| 79 | MP0000249_abnormal_blood_vessel | 0.94706481 |
| 80 | MP0005671_abnormal_response_to | 0.93787663 |
| 81 | MP0000371_diluted_coat_color | 0.93262497 |
| 82 | MP0008469_abnormal_protein_level | 0.93038740 |
| 83 | MP0000015_abnormal_ear_pigmentation | 0.92797299 |
| 84 | MP0000858_altered_metastatic_potential | 0.91947026 |
| 85 | MP0003828_pulmonary_edema | 0.90390553 |
| 86 | MP0003329_amyloid_beta_deposits | 0.88548735 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.86690458 |
| 88 | MP0000647_abnormal_sebaceous_gland | 0.85832218 |
| 89 | MP0001545_abnormal_hematopoietic_system | 0.84523259 |
| 90 | MP0005397_hematopoietic_system_phenotyp | 0.84523259 |
| 91 | MP0005076_abnormal_cell_differentiation | 0.83909005 |
| 92 | MP0002332_abnormal_exercise_endurance | 0.83737434 |
| 93 | MP0001851_eye_inflammation | 0.82336727 |
| 94 | MP0010771_integument_phenotype | 0.80484486 |
| 95 | MP0008874_decreased_physiological_sensi | 0.80333962 |
| 96 | MP0008004_abnormal_stomach_pH | 0.80129288 |
| 97 | MP0000579_abnormal_nail_morphology | 0.79293421 |
| 98 | MP0005310_abnormal_salivary_gland | 0.79209974 |
| 99 | MP0005174_abnormal_tail_pigmentation | 0.78474657 |
| 100 | MP0009763_increased_sensitivity_to | 0.77696348 |
| 101 | MP0005508_abnormal_skeleton_morphology | 0.77134519 |
| 102 | MP0004782_abnormal_surfactant_physiolog | 0.75892590 |
| 103 | MP0004233_abnormal_muscle_weight | 0.74998256 |
| 104 | MP0000689_abnormal_spleen_morphology | 0.74551580 |
| 105 | MP0002090_abnormal_vision | 0.74309926 |
| 106 | MP0001663_abnormal_digestive_system | 0.73011642 |
| 107 | MP0001216_abnormal_epidermal_layer | 0.72587383 |
| 108 | MP0005365_abnormal_bile_salt | 0.72246635 |
| 109 | MP0003795_abnormal_bone_structure | 0.71851788 |
| 110 | MP0005257_abnormal_intraocular_pressure | 0.71747165 |
| 111 | MP0003172_abnormal_lysosome_physiology | 0.71601740 |
| 112 | MP0004272_abnormal_basement_membrane | 0.71543024 |
| 113 | MP0005375_adipose_tissue_phenotype | 0.70687638 |
| 114 | MP0000465_gastrointestinal_hemorrhage | 0.69993763 |
| 115 | MP0005647_abnormal_sex_gland | 0.69869600 |
| 116 | MP0010329_abnormal_lipoprotein_level | 0.69714126 |
| 117 | MP0002971_abnormal_brown_adipose | 0.69514717 |
| 118 | MP0009115_abnormal_fat_cell | 0.69444437 |
| 119 | MP0000750_abnormal_muscle_regeneration | 0.69315146 |
| 120 | MP0008875_abnormal_xenobiotic_pharmacok | 0.67929061 |
| 121 | MP0010234_abnormal_vibrissa_follicle | 0.67352845 |
| 122 | MP0002693_abnormal_pancreas_physiology | 0.67071585 |
| 123 | MP0001756_abnormal_urination | 0.66739500 |
| 124 | MP0005165_increased_susceptibility_to | 0.66084860 |
| 125 | MP0000767_abnormal_smooth_muscle | 0.65486180 |
| 126 | MP0003091_abnormal_cell_migration | 0.64504347 |
| 127 | MP0003656_abnormal_erythrocyte_physiolo | 0.64475103 |
| 128 | MP0002108_abnormal_muscle_morphology | 0.63924784 |
| 129 | MP0010155_abnormal_intestine_physiology | 0.63473173 |
| 130 | MP0001915_intracranial_hemorrhage | 0.63404231 |
| 131 | MP0002006_tumorigenesis | 0.63123960 |
| 132 | MP0000733_abnormal_muscle_development | 0.62632315 |
| 133 | MP0002722_abnormal_immune_system | 0.61487911 |
| 134 | MP0010307_abnormal_tumor_latency | 0.59703789 |
| 135 | MP0000609_abnormal_liver_physiology | 0.59264507 |
| 136 | MP0002877_abnormal_melanocyte_morpholog | 0.57983962 |
| 137 | MP0002138_abnormal_hepatobiliary_system | 0.57940312 |
| 138 | MP0008260_abnormal_autophagy | 0.56485004 |
| 139 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.56223025 |
| 140 | MP0003646_muscle_fatigue | 0.56189661 |
| 141 | MP0005319_abnormal_enzyme/_coenzyme | 0.56165812 |
| 142 | MP0003186_abnormal_redox_activity | 0.55972181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 8.82665306 |
| 2 | Glomerulonephritis (HP:0000099) | 6.78639538 |
| 3 | Complement deficiency (HP:0004431) | 6.69148858 |
| 4 | Abnormality of complement system (HP:0005339) | 5.78145450 |
| 5 | Protrusio acetabuli (HP:0003179) | 4.59840260 |
| 6 | Premature rupture of membranes (HP:0001788) | 4.59047541 |
| 7 | Thick nail (HP:0001805) | 4.24169000 |
| 8 | Optic neuritis (HP:0100653) | 4.22860755 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 4.22860755 |
| 10 | Cerebral aneurysm (HP:0004944) | 4.14761382 |
| 11 | Alopecia of scalp (HP:0002293) | 4.06014396 |
| 12 | Aortic dissection (HP:0002647) | 4.03068653 |
| 13 | Nephritis (HP:0000123) | 4.02892341 |
| 14 | Premature loss of primary teeth (HP:0006323) | 3.97217074 |
| 15 | Recurrent abscess formation (HP:0002722) | 3.90774026 |
| 16 | Dysostosis multiplex (HP:0000943) | 3.89079986 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 3.86224640 |
| 18 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.83907633 |
| 19 | Osteolytic defects of the hand bones (HP:0009699) | 3.83907633 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.73330021 |
| 21 | Hemoptysis (HP:0002105) | 3.69254614 |
| 22 | Prostate neoplasm (HP:0100787) | 3.68780050 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.61955525 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.61955525 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 3.56680809 |
| 26 | Loss of speech (HP:0002371) | 3.47165947 |
| 27 | Arterial tortuosity (HP:0005116) | 3.43067173 |
| 28 | Follicular hyperkeratosis (HP:0007502) | 3.40220446 |
| 29 | Aortic aneurysm (HP:0004942) | 3.34774522 |
| 30 | Increased IgM level (HP:0003496) | 3.29501586 |
| 31 | Striae distensae (HP:0001065) | 3.29328492 |
| 32 | Stomatitis (HP:0010280) | 3.28830627 |
| 33 | Soft skin (HP:0000977) | 3.28158969 |
| 34 | Albinism (HP:0001022) | 3.26930082 |
| 35 | Pulmonary infiltrates (HP:0002113) | 3.25424558 |
| 36 | Vascular tortuosity (HP:0004948) | 3.24327261 |
| 37 | Peritonitis (HP:0002586) | 3.24210972 |
| 38 | Atrophic scars (HP:0001075) | 3.18001616 |
| 39 | Eczematoid dermatitis (HP:0000976) | 3.02546071 |
| 40 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.00793010 |
| 41 | Mutism (HP:0002300) | 2.97186706 |
| 42 | Dilatation of the ascending aorta (HP:0005111) | 2.95265049 |
| 43 | Abnormality of the prostate (HP:0008775) | 2.91357755 |
| 44 | Recurrent fungal infections (HP:0002841) | 2.91271448 |
| 45 | Vertebral compression fractures (HP:0002953) | 2.85092859 |
| 46 | Cheilitis (HP:0100825) | 2.81203152 |
| 47 | Neoplasm of head and neck (HP:0012288) | 2.80193840 |
| 48 | Esophageal neoplasm (HP:0100751) | 2.80193840 |
| 49 | Keratoconjunctivitis sicca (HP:0001097) | 2.78842880 |
| 50 | Mitral valve prolapse (HP:0001634) | 2.77690867 |
| 51 | Bladder diverticulum (HP:0000015) | 2.75337463 |
| 52 | Hematochezia (HP:0002573) | 2.73580596 |
| 53 | Neurofibrillary tangles (HP:0002185) | 2.69240284 |
| 54 | Disinhibition (HP:0000734) | 2.68729563 |
| 55 | Spontaneous hematomas (HP:0007420) | 2.67013314 |
| 56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.66920851 |
| 57 | Vasculitis (HP:0002633) | 2.66474153 |
| 58 | Agnosia (HP:0010524) | 2.63581529 |
| 59 | Increased connective tissue (HP:0009025) | 2.63396889 |
| 60 | Blue sclerae (HP:0000592) | 2.63131477 |
| 61 | Type 1 muscle fiber predominance (HP:0003803) | 2.61945104 |
| 62 | Spondylolisthesis (HP:0003302) | 2.58342638 |
| 63 | Increased serum ferritin (HP:0003281) | 2.55051770 |
| 64 | Gingivitis (HP:0000230) | 2.55002108 |
| 65 | Keratoconjunctivitis (HP:0001096) | 2.52787791 |
| 66 | Abnormality of nail color (HP:0100643) | 2.49457921 |
| 67 | Fragile skin (HP:0001030) | 2.48229251 |
| 68 | Nuclear cataract (HP:0100018) | 2.44371019 |
| 69 | Obstructive lung disease (HP:0006536) | 2.44277427 |
| 70 | Chronic obstructive pulmonary disease (HP:0006510) | 2.44277427 |
| 71 | Round ear (HP:0100830) | 2.41992555 |
| 72 | Inappropriate behavior (HP:0000719) | 2.41197804 |
| 73 | Malnutrition (HP:0004395) | 2.40801974 |
| 74 | Myocardial infarction (HP:0001658) | 2.37824876 |
| 75 | Gangrene (HP:0100758) | 2.37010625 |
| 76 | Recurrent viral infections (HP:0004429) | 2.36600813 |
| 77 | Axonal loss (HP:0003447) | 2.35766467 |
| 78 | Cervical subluxation (HP:0003308) | 2.33998427 |
| 79 | Abnormality of the endocardium (HP:0004306) | 2.33361229 |
| 80 | Wormian bones (HP:0002645) | 2.30554429 |
| 81 | Ankle contracture (HP:0006466) | 2.29766894 |
| 82 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.28428395 |
| 83 | Mucopolysacchariduria (HP:0008155) | 2.28428395 |
| 84 | Autoimmune thrombocytopenia (HP:0001973) | 2.26118212 |
| 85 | Abnormality of T cell number (HP:0011839) | 2.25032190 |
| 86 | Metaphyseal irregularity (HP:0003025) | 2.24703860 |
| 87 | T lymphocytopenia (HP:0005403) | 2.23971120 |
| 88 | Apathy (HP:0000741) | 2.23707525 |
| 89 | Nausea (HP:0002018) | 2.22536105 |
| 90 | Hypergammaglobulinemia (HP:0010702) | 2.20899852 |
| 91 | Autoimmune hemolytic anemia (HP:0001890) | 2.20494333 |
| 92 | Cerebral inclusion bodies (HP:0100314) | 2.18324557 |
| 93 | Myositis (HP:0100614) | 2.17054744 |
| 94 | Diminished motivation (HP:0000745) | 2.17022781 |
| 95 | Broad metatarsal (HP:0001783) | 2.14727951 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 2.13286737 |
| 97 | Urticaria (HP:0001025) | 2.13242374 |
| 98 | Shallow orbits (HP:0000586) | 2.12731901 |
| 99 | Meningitis (HP:0001287) | 2.12429610 |
| 100 | Amyloidosis (HP:0011034) | 2.11054146 |
| 101 | Memory impairment (HP:0002354) | 2.08196822 |
| 102 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.06196603 |
| 103 | Hyperextensible skin (HP:0000974) | 2.04811956 |
| 104 | Basal ganglia calcification (HP:0002135) | 2.04012142 |
| 105 | Abnormality of macrophages (HP:0004311) | 2.03635478 |
| 106 | Hypertensive crisis (HP:0100735) | 1.99512018 |
| 107 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.98862895 |
| 108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.98862895 |
| 109 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.98862895 |
| 110 | Palmoplantar hyperkeratosis (HP:0000972) | 1.97471417 |
| 111 | Abnormality of the pleura (HP:0002103) | 1.96368410 |
| 112 | Chronic otitis media (HP:0000389) | 1.96203621 |
| 113 | Pustule (HP:0200039) | 1.95929992 |
| 114 | Arterial thrombosis (HP:0004420) | 1.94193391 |
| 115 | Neuronal loss in central nervous system (HP:0002529) | 1.94117392 |
| 116 | Asymmetric septal hypertrophy (HP:0001670) | 1.94020828 |
| 117 | Joint stiffness (HP:0001387) | 1.93678868 |
| 118 | Recurrent bronchitis (HP:0002837) | 1.93211858 |
| 119 | Venous abnormality (HP:0002624) | 1.92116985 |
| 120 | Polyneuropathy (HP:0001271) | 1.90808943 |
| 121 | IgA deficiency (HP:0002720) | 1.90521179 |
| 122 | Abnormality of glycolipid metabolism (HP:0010969) | 1.89278560 |
| 123 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.89278560 |
| 124 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.89278560 |
| 125 | Spinal rigidity (HP:0003306) | 1.88701690 |
| 126 | Periodontitis (HP:0000704) | 1.88571447 |
| 127 | Chest pain (HP:0100749) | 1.88273622 |
| 128 | Encephalitis (HP:0002383) | 1.87836665 |
| 129 | Facial diplegia (HP:0001349) | 1.87236519 |
| 130 | Recurrent skin infections (HP:0001581) | 1.86639140 |
| 131 | Muscle fiber splitting (HP:0003555) | 1.86245805 |
| 132 | Anorexia (HP:0002039) | 1.85630406 |
| 133 | Biconcave vertebral bodies (HP:0004586) | 1.83531788 |
| 134 | Progressive neurologic deterioration (HP:0002344) | 1.83504315 |
| 135 | Abnormality of dentin (HP:0010299) | 1.81702131 |
| 136 | Venous insufficiency (HP:0005293) | 1.80681550 |
| 137 | Abnormality of the lumbar spine (HP:0100712) | 1.78082903 |
| 138 | Palmar hyperkeratosis (HP:0010765) | 1.77555099 |
| 139 | Interstitial pulmonary disease (HP:0006530) | 1.77347672 |
| 140 | Ulnar deviation of the wrist (HP:0003049) | 1.76750245 |
| 141 | Exercise-induced muscle cramps (HP:0003710) | 1.76001778 |
| 142 | Mediastinal lymphadenopathy (HP:0100721) | 1.72626612 |
| 143 | Orchitis (HP:0100796) | 1.70054142 |
| 144 | Plantar hyperkeratosis (HP:0007556) | 1.69930122 |
| 145 | Increased IgE level (HP:0003212) | 1.69627661 |
| 146 | Slender build (HP:0001533) | 1.69146679 |
| 147 | Genu recurvatum (HP:0002816) | 1.68337235 |
| 148 | Aneurysm (HP:0002617) | 1.66632089 |
| 149 | Cellulitis (HP:0100658) | 1.64581941 |
| 150 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.63663562 |
| 151 | Purpura (HP:0000979) | 1.62980498 |
| 152 | Conjunctival telangiectasia (HP:0000524) | 1.60799766 |
| 153 | Gastrointestinal infarctions (HP:0005244) | 1.60767427 |
| 154 | Right ventricular cardiomyopathy (HP:0011663) | 1.60592202 |
| 155 | Xanthomatosis (HP:0000991) | 1.60525727 |
| 156 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.60087112 |
| 157 | Hypotrichosis (HP:0001006) | 1.58968690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 6.41783794 |
| 2 | TGFBR2 | 4.38780349 |
| 3 | IRAK3 | 4.25428697 |
| 4 | TRIB3 | 3.85761350 |
| 5 | TYK2 | 3.60472260 |
| 6 | ERN1 | 2.89001872 |
| 7 | GRK7 | 2.43120602 |
| 8 | NME2 | 2.27608441 |
| 9 | SCYL2 | 2.15463848 |
| 10 | CAMK1D | 2.12437553 |
| 11 | TTN | 2.10185452 |
| 12 | EPHB1 | 2.02035499 |
| 13 | TBK1 | 1.93177419 |
| 14 | BMPR2 | 1.87173860 |
| 15 | FGFR4 | 1.84259112 |
| 16 | RIPK1 | 1.75515587 |
| 17 | LIMK1 | 1.75224597 |
| 18 | KIT | 1.73733049 |
| 19 | PIK3CG | 1.70295963 |
| 20 | TXK | 1.70105140 |
| 21 | TAOK2 | 1.68285648 |
| 22 | CAMK1G | 1.58557870 |
| 23 | EPHA3 | 1.55431181 |
| 24 | TESK1 | 1.55043698 |
| 25 | JAK1 | 1.54420161 |
| 26 | FGFR3 | 1.53369722 |
| 27 | EPHB2 | 1.44281585 |
| 28 | CAMKK2 | 1.41778468 |
| 29 | FGR | 1.39878775 |
| 30 | CSK | 1.38895194 |
| 31 | PKN2 | 1.37224870 |
| 32 | ERBB3 | 1.34229700 |
| 33 | PTK6 | 1.33485696 |
| 34 | KDR | 1.29747752 |
| 35 | CAMKK1 | 1.17749276 |
| 36 | DDR2 | 1.15694083 |
| 37 | JAK3 | 1.11202936 |
| 38 | LRRK2 | 1.09523790 |
| 39 | NEK9 | 1.08744095 |
| 40 | MATK | 1.07663155 |
| 41 | ZAP70 | 1.02459556 |
| 42 | MOS | 1.01695348 |
| 43 | CDC42BPA | 1.00788269 |
| 44 | PDGFRA | 1.00153699 |
| 45 | MAP3K11 | 0.98386535 |
| 46 | PAK4 | 0.97303421 |
| 47 | MAP3K3 | 0.96834141 |
| 48 | JAK2 | 0.96133654 |
| 49 | MAP3K10 | 0.94268012 |
| 50 | TGFBR1 | 0.90284403 |
| 51 | TAOK1 | 0.89386336 |
| 52 | CHUK | 0.89328228 |
| 53 | CSF1R | 0.88990214 |
| 54 | MAP4K1 | 0.88822930 |
| 55 | IRAK4 | 0.88328337 |
| 56 | CDK6 | 0.87423558 |
| 57 | ACVR1B | 0.86029347 |
| 58 | TAOK3 | 0.85627363 |
| 59 | PTK2B | 0.85465313 |
| 60 | HCK | 0.85052638 |
| 61 | PRPF4B | 0.84467320 |
| 62 | ILK | 0.82634701 |
| 63 | NTRK1 | 0.81227258 |
| 64 | BMX | 0.80380816 |
| 65 | IKBKE | 0.78428207 |
| 66 | IRAK1 | 0.76820254 |
| 67 | PDK2 | 0.75966331 |
| 68 | FES | 0.75197974 |
| 69 | FER | 0.74942893 |
| 70 | RIPK4 | 0.73869687 |
| 71 | ITK | 0.72692124 |
| 72 | FGFR1 | 0.71990417 |
| 73 | DYRK1B | 0.71915782 |
| 74 | MAP3K14 | 0.71704972 |
| 75 | ABL2 | 0.71187989 |
| 76 | MST4 | 0.70653498 |
| 77 | RPS6KA4 | 0.70405327 |
| 78 | DMPK | 0.69111726 |
| 79 | PAK2 | 0.67291872 |
| 80 | TRPM7 | 0.65970312 |
| 81 | MET | 0.65242240 |
| 82 | MAP2K3 | 0.64976423 |
| 83 | STK10 | 0.64455296 |
| 84 | EGFR | 0.64100456 |
| 85 | KSR1 | 0.62289033 |
| 86 | LYN | 0.62073386 |
| 87 | ADRBK2 | 0.61393898 |
| 88 | RET | 0.58389430 |
| 89 | DAPK2 | 0.57339017 |
| 90 | MAPK11 | 0.55411898 |
| 91 | MAPKAPK2 | 0.54324567 |
| 92 | MAP3K13 | 0.53861418 |
| 93 | MAP2K1 | 0.53656695 |
| 94 | PRKCD | 0.53603970 |
| 95 | MAPKAPK5 | 0.53012134 |
| 96 | LCK | 0.51572200 |
| 97 | MYLK | 0.50995629 |
| 98 | MAP3K5 | 0.50216527 |
| 99 | FYN | 0.49870516 |
| 100 | INSR | 0.49371264 |
| 101 | BTK | 0.49310015 |
| 102 | HIPK2 | 0.49226210 |
| 103 | MAPKAPK3 | 0.46979090 |
| 104 | IGF1R | 0.45928022 |
| 105 | PLK2 | 0.42594908 |
| 106 | PRKD1 | 0.42369364 |
| 107 | MAP3K2 | 0.42033724 |
| 108 | SYK | 0.41342383 |
| 109 | IRAK2 | 0.41145757 |
| 110 | PBK | 0.40465385 |
| 111 | TESK2 | 0.39909765 |
| 112 | TYRO3 | 0.39450507 |
| 113 | GSK3A | 0.39425992 |
| 114 | EIF2AK2 | 0.39311650 |
| 115 | MAP3K6 | 0.38749093 |
| 116 | ABL1 | 0.38215734 |
| 117 | ROCK2 | 0.37945790 |
| 118 | BCKDK | 0.36748404 |
| 119 | FRK | 0.36640102 |
| 120 | LATS2 | 0.35882911 |
| 121 | IKBKB | 0.35423242 |
| 122 | PIM2 | 0.34851508 |
| 123 | MAP3K1 | 0.34762931 |
| 124 | PHKG1 | 0.33788021 |
| 125 | PHKG2 | 0.33788021 |
| 126 | PDGFRB | 0.33768944 |
| 127 | PAK6 | 0.33523614 |
| 128 | PTK2 | 0.33352282 |
| 129 | MAP3K4 | 0.33128310 |
| 130 | TAF1 | 0.27653897 |
| 131 | MAPK4 | 0.27317248 |
| 132 | RPS6KA5 | 0.27009542 |
| 133 | MAP2K6 | 0.26860396 |
| 134 | PKN1 | 0.25868956 |
| 135 | RPS6KC1 | 0.25068889 |
| 136 | RPS6KL1 | 0.25068889 |
| 137 | MKNK1 | 0.24788690 |
| 138 | RPS6KA6 | 0.21048964 |
| 139 | PRKCQ | 0.20655581 |
| 140 | PIM1 | 0.19842237 |
| 141 | MARK3 | 0.19544869 |
| 142 | RPS6KA2 | 0.18291672 |
| 143 | PRKG2 | 0.14781723 |
| 144 | TNK2 | 0.10791754 |
| 145 | CLK1 | 0.10588157 |
| 146 | PDPK1 | 0.08870124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.87876622 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 4.06668704 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.98666429 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.56857528 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.53561330 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 3.12387610 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.06785891 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.82857879 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.63260073 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.58567531 |
| 11 | Prion diseases_Homo sapiens_hsa05020 | 2.46048001 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 2.45857723 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.07844206 |
| 14 | Phagosome_Homo sapiens_hsa04145 | 2.07466041 |
| 15 | Malaria_Homo sapiens_hsa05144 | 2.03159200 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.93766634 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.89633163 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.78321167 |
| 19 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.74237856 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.62734718 |
| 21 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.59649815 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.49827933 |
| 23 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.46131705 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44577515 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.39442358 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.35704311 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.30227326 |
| 28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.28678494 |
| 29 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.28603427 |
| 30 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27937350 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26447275 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.25926899 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.22217793 |
| 34 | Amoebiasis_Homo sapiens_hsa05146 | 1.21429333 |
| 35 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20827490 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.19040544 |
| 37 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.17735280 |
| 38 | Legionellosis_Homo sapiens_hsa05134 | 1.16618661 |
| 39 | Endocytosis_Homo sapiens_hsa04144 | 1.16457908 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.13848891 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.13341167 |
| 42 | Focal adhesion_Homo sapiens_hsa04510 | 1.11673067 |
| 43 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.07864177 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.06268785 |
| 45 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.02257009 |
| 46 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.99145347 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 0.92133345 |
| 48 | Adherens junction_Homo sapiens_hsa04520 | 0.91560564 |
| 49 | Measles_Homo sapiens_hsa05162 | 0.87713729 |
| 50 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85904341 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85503595 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80976496 |
| 53 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79540159 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79038073 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.77193577 |
| 56 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.73725411 |
| 57 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73507144 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.68773615 |
| 59 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68266568 |
| 60 | Influenza A_Homo sapiens_hsa05164 | 0.67903766 |
| 61 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.66482194 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66376450 |
| 63 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65621875 |
| 64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64757046 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64538757 |
| 66 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.62261620 |
| 67 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62028132 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59671819 |
| 69 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.59286944 |
| 70 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.59286030 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58152971 |
| 72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56795674 |
| 73 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.56124100 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54521083 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.52838129 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.51179835 |
| 77 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50717262 |
| 78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49258452 |
| 79 | Hepatitis B_Homo sapiens_hsa05161 | 0.48098204 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47989371 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.46471050 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45765003 |
| 83 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.45671664 |
| 84 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.44186298 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43773965 |
| 86 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.43461230 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43073207 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42753684 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40861914 |
| 90 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.40550548 |
| 91 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.39078678 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38471970 |
| 93 | Renin secretion_Homo sapiens_hsa04924 | 0.37539645 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.36738115 |
| 95 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.34946830 |
| 96 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.34617642 |
| 97 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.34564891 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32886165 |
| 99 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.32786457 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32315383 |
| 101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.31756812 |
| 102 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.31445621 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31313697 |
| 104 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.31188191 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30630328 |
| 106 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.30343583 |
| 107 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.29739776 |
| 108 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29182663 |
| 109 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.29115755 |
| 110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29084424 |
| 111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.29006303 |
| 112 | Bladder cancer_Homo sapiens_hsa05219 | 0.28986676 |
| 113 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.28329258 |
| 114 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.27773344 |
| 115 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.27736588 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.27714330 |
| 117 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.27356828 |
| 118 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.26954790 |
| 119 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.26587132 |
| 120 | Gap junction_Homo sapiens_hsa04540 | 0.25054174 |
| 121 | ABC transporters_Homo sapiens_hsa02010 | 0.23955353 |
| 122 | Glioma_Homo sapiens_hsa05214 | 0.22928007 |
| 123 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.19721798 |
| 124 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.16815541 |
| 125 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.15366449 |
| 126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.13066401 |
| 127 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.12738406 |
| 128 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.10762508 |
| 129 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.02399330 |
| 130 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.01221385 |
| 131 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.00066059 |
| 132 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0766996 |
| 133 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.0723268 |
| 134 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | -0.0196842 |

